Abstract
Introduction
Resveratrol is a natural polyphenolic compound with a stilbene structure endowed with multiple health-promoting effects. Among phenolic compounds, resveratrol is assigned a leading role in the health-promoting effects of red wine.
Methods
The aim of the study was to assess the effect of resveratrol on the cardiovascular system in the experimental and clinical studies conducted so far. Moreover, the paper discusses the results of the most recent meta-analyses assessing resveratrol’s therapeutic effect on the cardiovascular system in humans.
Results
In animal and preclinical studies, resveratrol has demonstrated a wide physiological and biochemical spectrum of activity, including antioxidant, anti-inflammatory, antiplatelet, and anticoagulant activities, which translated into its health-promoting effects on the cardiovascular system. The performed meta-analyses allow to confirm such an impact, however, after the assessment with the use of the SYRCLE’s tool, these studies are burdened with a high risk of bias, and the results are not clearly presented.
Conclusion
Despite numerous articles and clinical studies, the convincing beneficial mechanisms of resveratrol as well as its health-promoting effects in cardiovascular diseases have not been clearly confirmed in humans. Therefore, there is a need for further clinical studies, especially randomized, double-blind, placebo-controlled trials to objectively confirm the possible health-promoting effects of this substance and to determine both the efficacy and safety, and possible therapeutic potential.
Similar content being viewed by others
References
Trela BC, Waterhouse AL (1996) Resveratrol Isomeric molar absorptivities and stability. J Agric Food Chem 44:1253–1257. https://doi.org/10.1021/jf9504576
Pantusa M, Bartucci R, Rizzuti B (2014) Stability of trans-resveratrol associated with transport proteins. J Agric Food Chem 62:4384–4391. https://doi.org/10.1021/jf405584a
Gambini J, Inglés M, Olaso G et al (2015) Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid Med Cell Longev. https://doi.org/10.1155/2015/837042
Takaoka M (1939) Resveratrol, a new phenolic compound, from Veratrum grandiflorum. Nippon Kagaku Kaishi (J Chem Soc Jpn) 60:1090–1100. https://doi.org/10.1246/nikkashi1921.60.1090
Burns J, Yokota T, Ashihara H et al (2002) Plant foods and herbal sources of resveratrol. J Agric Food Chem 50:3337–3340. https://doi.org/10.1021/jf0112973
Sales JM, Resurreccion AV (2014) Resveratrol in peanuts. Crit Rev Food Sci Nutr 54:734–770. https://doi.org/10.1080/10408398.2011.606928
Counet C, Callemien D, Collin S (2006) Chocolate and cocoa: new sources of trans-resveratrol and trans-piceid. Food Chem 98:649–657. https://doi.org/10.1016/j.foodchem.2005.06.030
Presta MA, Bruyneel B, Zanella R et al (2009) Determination of Flavonoids and Resveratrol in Wine by Turbulent-Flow Chromatography-LC-MS. Chromatographia 69:167–173. https://doi.org/10.1365/s10337-009-1132-x
Walle T, Hsieh F, DeLegge MH et al (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377–1382. https://doi.org/10.1124/dmd.104.000885
Smoliga JM, Blanchard O (2014) Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution? Molecules 19:17154–17172. https://doi.org/10.3390/molecules191117154
Bonnefont-Rousselot D (2016) Resveratrol and cardiovascular diseases. Nutrients 8:250. https://doi.org/10.3390/nu8050250
Breuss JM, Atanasov AG, Uhrin P (2019) Resveratrol and its effects on the vascular system. Int J Mol Sci 20:1523. https://doi.org/10.3390/ijms20071523
Cheng CK, Luo JY, Lau CW (2020) Pharmacological basis and new insights of resveratrol action in the cardiovascular system. Br J Pharmacol 177:1258–1277. https://doi.org/10.1111/bph.14801
Yashiro T, Nanmoku M, Shimizu M et al (2012) Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins. Atherosclerosis 220:369–374. https://doi.org/10.1016/j.atherosclerosis.2011.11.006
Berrougui H, Grenier G, Loued S et al (2009) A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux. Atherosclerosis 207:420–427. https://doi.org/10.1016/j.atherosclerosis.2009.05.017
Sahebkar A (2013) Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 71:822–835. https://doi.org/10.1111/nure.12081
Vislocky LM, Fernandez ML (2010) Biomedical effects of grape products. Nutr Rev 68:656–670. https://doi.org/10.1111/j.1753-4887.2010.00335.x
Xia N, Daiber A, Forstermann U, Li H (2017) Antioxidant effects of resveratrol in the cardiovascular system. Br J Pharmacol 174:1633–1646. https://doi.org/10.1111/bph.13492
Frombaum M, Le Clanche S, Bonnefont-Rousselot D et al. (2012) Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and‚ NO bioavailability: potential benefits to cardiovascular diseases. Biochimie 94:269–276. https://doi.org/10.1016/j.biochi.2011.11.001
Wang Z, Huang Y, Zou J (2002) Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med 9:77–79. https://doi.org/10.3892/ijmm.9.1.77
Pace-Asciak CR, Hahn S, Diamandis EP (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 235:207–219. https://doi.org/10.1016/0009-8981(95)06045-1
Bertelli AA, Giovannini L, Giannessi DA et al. (1995) Antiplatelet activity of synthetic and natural resveratrol in red wine. NIH National library of medicine. https://pubmed.ncbi.nlm.nih.gov/7499059/. Accessed 03 November 2020
Ghanim H, Sia CL, Korzeniewski K et al (2011) A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab 96:1409–1414. https://doi.org/10.1210/jc.2010-1812
Malaguarnera L (2019) Influence of resveratrol on the immune response. Nutrients 11:946. https://doi.org/10.3390/nu11050946
Das S, Das DK (2007) Anti-inflammatory responses of resveratrol. Inflamm. Allergy Drug Targets 6:168–173. https://doi.org/10.2174/187152807781696464
Wallerath T, Deckert G, Ternes T et al (2002) Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106:1652–1658. https://doi.org/10.1161/01.CIR.0000029925.18593.5C
Leikert JF, Räthel TR, Wohlfart P et al (2002) Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106:1614–1617. https://doi.org/10.1161/01.CIR.0000034445.31543.43
Takahashi S, Nakashima Y (2012) Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells. Br J Nutr 107:774–780. https://doi.org/10.1017/S0007114511003588
Cheng AS, Cheng YH, Lee CY et al (2015) Resveratrol protects against methylglyoxal-induced hyperglycemia and pancreatic damage in vivo. Nutrients 7:2850–2865. https://doi.org/10.3390/nu7042850
Szkudelski T, Szkudelska K (2015) Resveratrol and diabetes: from animal to human studies. Biochim Biophys Acta 1852:1145–1154. https://doi.org/10.1016/j.bbadis.2014.10.013
Hausenblas HA, Schoulda JA, Smoliga JM (2015) Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus: systematic review and meta-analysis. Mol Nutr Food Res 59:147–159. https://doi.org/10.1002/mnfr.201400173
Kong W, Chen LL, Zheng J et al (2015) Resveratrol supplementation restores high-fat diet-induced insulin secretion dysfunction by increasing mitochondrial function in islet. Exp Biol Med 240:220–229. https://doi.org/10.1177/1535370214548998
Andrade EF, Orlando DR, Araújo AMS et al (2019) Can resveratrol treatment control the progression of induced periodontal disease? A systematic review and meta-analysis of preclinical studies. Nutrients 11:953. https://doi.org/10.3390/nu11050953
Chen JY, Zhu Q, Zhang S et al (2019) Resveratrol in experimental Alzheimer’s disease models: A systematic review of preclinical studies. Pharmacol Res 150:104476. https://doi.org/10.1016/j.phrs.2019.104476
Toro MD, Nowomiejska K, Avitabile T et al (2019) Effect of Resveratrol on In Vitro and In Vivo Models of Diabetic Retinophathy: A Systematic Review. Int J Mol Sci 20:3503. https://doi.org/10.3390/ijms20143503
Akbari M, Tamtaji OR, Lankarani KB (2019) The effects of resveratrol supplementation on endothelial function and blood pressures among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. High Blood Press Cardiovasc Prev 26:305–319. https://doi.org/10.1007/s40292-019-00324-6
Heilbronn LK, Ravussin E (2003) Calorie restriction and aging: review of the literature and implication for studies in humans. Am J Clin Nutr 78:361–369. https://doi.org/10.1093/ajcn/78.3.361
Das DK, Mukherjee S, Ray D (2010) Resveratrol and red wine, healthy heart and longevity. Heart Failure Reviews 15:467–477. https://doi.org/10.1007/s10741-010-9163-9
Lee SH, Lee JH, Lee HY et al (2019) Sirtuin signaling in cellular senescence and aging. BMB Rep 52:24–34. https://doi.org/10.5483/BMBRep.2019.52.1.290
Cao D, Wang M, Qiu X et al (2015) Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol. Genes Dev 29:1316–1325. https://doi.org/10.1101/gad.265462.115
Porcu M, Chiarugi A (2005) The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. Trends Pharmacol Sci 26:94–103. https://doi.org/10.1016/j.tips.2004.12.009
Fernandez-Quintela A, Milton-Laskibar I, Gonzalez M et al (2017) Antiobesity effects of resveratrol: which tissues are involved? Ann N Y Acad Sci 403:118–131. https://doi.org/10.3389/fendo.2019.00413
Tabrizi R, Tamtaji OR, Lankarani KB (2018) The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 13:1–16. https://doi.org/10.1080/10408398.2018.1529654
Zhao Y, Chen B, Shen J (2017) The beneficial effects of quercetin, curcumin, and resveratrol in obesity. Oxid Med Cell Longev 2017:1459497. https://doi.org/10.1155/2017/1459497
Li YR, Li S, Lin CC (2018) Effect of resveratrol and pterostilbene on aging and longevity. Biofactors 44:69–82. https://doi.org/10.1002/biof.1400
Bastianetto S, Ménard C, Quirion R (2015) Neuroprotective action of resveratrol. Biochimica et Biophysica Acta 6:1195–1201. https://doi.org/10.1016/j.bbadis.2014.09.011
Marambaud P, Zhao H, Davies P (2005) Resveratrol promotes clearance of Alzheimer’s disease amyloid-beta peptides. J Biol Chem 280:37377–37382. https://doi.org/10.1074/jbc.M508246200
Zhu X, Li W, Li Y (2019) The antidepressant- and anxiolytic-like effects of resveratrol: Involvement of phosphodiesterase-4D inhibition. Neuropharmacology 15;153:20–31. https://doi.org/10.1016/j.neuropharm.2019.04.022
Lange KW, Li S (2018) Resveratrol, pterostilbene, and dementia. Biofactors 44:83–90. https://doi.org/10.1002/biof.1396
Cicero AFG, Ruscica M, Banach M (2019) Resveratrol and cognitive decline: a clinician perspective. Arch Med Sci 15:936–943. https://doi.org/10.5114/aoms.2019.85463
Bhullar KS, Hubbard BP (2015) Lifespan and healthspan extension by resveratrol. Biochim. Biophys Acta 1852:1209–1218. https://doi.org/10.1016/j.bbadis.2015.01.012
Hector KL, Lagisz M, Nakagawa S (2012) The effect of resveratrol on longevity across species: a meta-analysis. Biology Letters 8:790–793. https://doi.org/10.1098/rsbl.2012.0316
Fogacci F, Tocci G, Presta V et al (2019) Effect of resveratrol on blood pressure: a systematic review and meta-analysis of randomized, controlled, clinical trials. Crit Rev Food Sci Nutr 59:1605–1618. https://doi.org/10.1080/10408398.2017.1422480
Liu Y, Ma W, Zhang P et al (2015) Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials. Clin Nutr 34:27–34. https://doi.org/10.1016/j.clnu.2014.03.009
Mousavi SM, Milajerdi A, Sheikhi A et al (2019) Resveratrol supplementation significantly influences obesity measures: a systematic review and dose-response meta-analysis of randomized controlled trials. Obes Rev 20:487–498. https://doi.org/10.1111/obr.12775
Tabrizi R, Tamtaji OR, Lankarani K et al (2020) The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 60:375–390. https://doi.org/10.1080/10408398.2018.1529654
Zhu X, Wu C, Qiu S (2017) Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis. Nutr Metab 14:60. https://doi.org/10.1186/s12986-017-0217-z
Haghighatdoost F, Hariri M (2018) Effect of resveratrol on lipid profile: an updated systematic review and meta-analysis on randomized clinical trials. Pharmacol Res 129:141–150. https://doi.org/10.1016/j.phrs.2017.12.033
Kjaer TN, Ornstru MJ, Poulsen MM et al (2017) No beneficial effects of resveratrol on the metabolic syndrome: a randomized placebo-controlled clinical trial. J Clin Endocrinol Metab 102:1642–1651. https://doi.org/10.1210/jc.2016-2160
Haghighatdoost F, Hariri M (2019) Can resveratrol supplement change inflammatory mediators? A systematic review and meta-analysis on randomized clinical trials. Eur J Clin Nutr 73:345–355. https://doi.org/10.1038/s41430-018-0253-4
Koushki M, Dashatan NA, Meshkani R (2018) Effect of resveratrol supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. Clin Ther 40:1180–1192. https://doi.org/10.1016/j.clinthera.2018.05.015
Sahebkar A, Serban C, Ursoniu S et al (2015) Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors–results from a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol 189:47–55. https://doi.org/10.1016/j.ijcard.2015.04.008
Magyar K, Halmosi R, Palfi A et al (2012) Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Microcirc 50:179–187. https://doi.org/10.3233/CH-2011-1424
Raj P, Zieroth S, Netticadan T (2015) An overview of the efficacy of resveratrol in the management of ischemic heart disease. Ann N Y Acad Sci 1348:55–67. https://doi.org/10.1111/nyas.12828
Raj P, Louis XL, Thandapilly SJ et al (2014) Potential of resveratrol in the treatment of heart failure. Life Sci 95:63–71. https://doi.org/10.1016/j.lfs.2013.12.011
Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523–1526. https://doi.org/10.1016/0140-6736(92)91277-f
Stervbo U, Vang O, Bonnesen C (2007) A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chem 101:449–457. https://doi.org/10.1016/j.foodchem.2006.01.047
Pastor RF, Restani P, Di Lorenzo C (2019) Resveratrol, human health and winemaking perspectives. Crit Rev Food Sci Nutr 59:1237–1255. https://doi.org/10.1016/j.foodchem.2006.01.047
Chow HH, Garland LL, Hsu CH et al (2010) Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res (Phila) 3:1168–1175. https://doi.org/10.1158/1940-6207.CAPR-09-0155
Brasnyó P, Molnár GA, Mohás M et al (2011) Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 106:383–389. https://doi.org/10.1017/S0007114511000316
Jeandet P, Bessis R, Maume BF et al (1993) Analysis of resveratrol in burgundy wines. J Wine Res 4:79. https://doi.org/10.1080/09571269308717954
Romero-Pérez AI, Lamuela-Raventós RM, Buxaderas S (1996) Torre-Boronat MC. Resveratrol and piceid as varietal markers of white wines. J Agric Food Chem 44:1975–1978. https://doi.org/10.1080/09571269308717954
Cvejic JM, Djekic SV, Petrovic AV (2010) Determination of trans- and cis-resveratrol in Serbian commercial wines. J Chromatogr Sci 48:229–234. https://doi.org/10.1080/09571269308717954
Global Agricultural Information Network (2015) Wine Annual Report and Statistics 2015 (GAIN Report Number IT1512) https://apps.fas.usda.gov/newgainapi/api/report/downloadreportbyfilename?filename=Wine%20Annual_Rome_EU-28_3-16-2015.pdf.
Dudley J, Das S, Mukherjee S et al (2009) Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J Nutr Biochem 20:443–452. https://doi.org/10.1016/j.jnutbio.2008.05.003
Pezzuto JM (2019) Resveratrol: twenty years of growth, development and controversy. Biomol Ther (Seoul) 27:1–14. https://doi.org/10.4062/biomolther.2018.176
Author information
Authors and Affiliations
Contributions
MC—conception and design of the article, interpreting the relevant literature, drafting of manuscript;
DR—conception and design of the article, interpreting the relevant literature, drafting of manuscript;
ŁW—interpreting the relevant literature, drafting of manuscript;
JB—interpreting the relevant literature, drafting of manuscript;
SS—conception and design of the article, interpreting the relevant literature;
RB—literature review, drafting of manuscript;
AS—literature review, critical revision;
GG—critical revision, proofreading of the version for publication.
All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Ethics approval
Not applicable
Consent to participate
Not applicable
Consent for publication
Not applicable
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chudzińska, M., Rogowicz, D., Wołowiec, Ł. et al. Resveratrol and cardiovascular system—the unfulfilled hopes. Ir J Med Sci 190, 981–986 (2021). https://doi.org/10.1007/s11845-020-02441-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-020-02441-x